{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -5.37635, "regularMarketPrice": 3.08, "marketState": "PRE", "currency": "USD", "exchange": "NCM", "shortName": "Nutriband Inc.", "longName": "Nutriband Inc.", "messageBoardId": "finmb_345353860", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChangePercent": -0.09277817, "twoHundredDayAverage": 3.8489683, "twoHundredDayAverageChange": -0.76896834, "twoHundredDayAverageChangePercent": -0.19978558, "marketCap": 24126102, "forwardPE": -13.391304, "priceToBook": 2.8153565, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-01", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1633095000000, "priceHint": 4, "regularMarketChange": -0.17500019, "regularMarketTime": 1684175148, "regularMarketDayHigh": 3.09, "regularMarketDayRange": "3.04 - 3.09", "regularMarketDayLow": 3.04, "regularMarketVolume": 1690, "regularMarketPreviousClose": 3.255, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 8, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 3.09, "averageDailyVolume3Month": 8580, "averageDailyVolume10Day": 9020, "fiftyTwoWeekLowChange": 0.67005086, "fiftyTwoWeekLowChangePercent": 0.27803528, "fiftyTwoWeekRange": "2.409949 - 6.981132", "fiftyTwoWeekHighChange": -3.901132, "fiftyTwoWeekHighChangePercent": -0.55881083, "fiftyTwoWeekLow": 2.409949, "fiftyTwoWeekHigh": 6.981132, "dividendDate": 1563926400, "earningsTimestamp": 1682506740, "earningsTimestampStart": 1685444340, "earningsTimestampEnd": 1685966400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.5, "epsForward": -0.23, "epsCurrentYear": -0.23, "priceEpsCurrentYear": -13.391304, "sharesOutstanding": 7833150, "bookValue": 1.094, "fiftyDayAverage": 3.39498, "fiftyDayAverageChange": -0.31498003, "displayName": "Nutriband", "symbol": "NTRB"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "121 South Orange Avenue", "address2": "Suite 1500", "city": "Orlando", "state": "FL", "zip": "32801", "country": "United States", "phone": "407 377 6695", "website": "https://nutriband.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Serguei  Melnik", "age": 48, "title": "Founder, Pres, Company Sec. & Exec. Chairman", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": {"raw": 200000, "fmt": "200k", "longFmt": "200,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gareth  Sheridan", "age": 32, "title": "Founder, CEO & Director", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": {"raw": 200000, "fmt": "200k", "longFmt": "200,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gerald  Goodman", "age": 74, "title": "CFO & Chief Accounting Officer", "yearBorn": 1948, "fiscalYear": 2023, "totalPay": {"raw": 160000, "fmt": "160k", "longFmt": "160,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alan  Smith Ph.D.", "age": 56, "title": "COO & Pres of 4P Therapeutics", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": {"raw": 179000, "fmt": "179k", "longFmt": "179,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrick  Ryan", "age": 36, "title": "Chief Technical Officer", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jeffrey  Patrick Pharm.D.", "age": 52, "title": "Chief Scientific Officer", "yearBorn": 1970, "fiscalYear": 2022, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tyler  Overk", "age": 38, "title": "Pres of Active Intelligence", "yearBorn": 1984, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400}}], "error": null}}